Mechanical Thrombectomy in Acute Stroke Patients with Moderate to Severe Pre-Stroke Disability.

Details

Ressource 1Download: 36221943_BIB_BFD8A2B26E08.pdf (129.06 [Ko])
State: Public
Version: Final published version
License: CC BY-NC 4.0
Serval ID
serval:BIB_BFD8A2B26E08
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Mechanical Thrombectomy in Acute Stroke Patients with Moderate to Severe Pre-Stroke Disability.
Journal
Journal of stroke
Author(s)
Sykora M., Michel P., Strambo D., Krebs S., Ferrari J., Posekany A., Mikšová D., Hermann K., Gattringer T., Gizewski E., Deutschmann H., Neumann C., Lang W.
ISSN
2287-6391 (Print)
ISSN-L
2287-6391
Publication state
Published
Issued date
09/2022
Peer-reviewed
Oui
Volume
24
Number
3
Pages
396-403
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
Abstract
Studies on mechanical thrombectomy (MT) in acute ischemic stroke (AIS) patients with preexisting disability are limited. We aimed to compare the outcomes of MT versus best medical treatment (BMT) in these patients.
In the nationwide Austrian registry and Swiss monocentric registry, we identified 462 AIS patients with pre-stroke disability (modified Rankin Scale [mRS] score ≥3) and acute large vessel occlusion. The primary outcome was returning to pre-stroke mRS or better at 3 months. Secondary outcomes were early neurological improvement (National Institutes of Health Stroke Scale score improvement ≥8 at 24 to 48 hours), 3-month mortality, and symptomatic intracerebral hemorrhage (sICH). Multivariable regression models and propensity score matching (PSM) were used for statistical analyses.
Compared with the BMT group (n=175), the MT group (n=175) had younger age, more severe strokes, and lower pre-stroke mRS, but similar proportion of receiving intravenous thrombolysis. MT was associated with higher odds of returning to baseline mRS or better at 3 months (adjusted odds ratio [aOR], 2.5; 95% confidence interval [CI], 1.39 to 4.47), early neurological improvement (aOR, 2.62; 95% CI, 1.41 to 4.88), and lower risk of 3-month mortality (aOR, 0.29; 95% CI, 0.18 to 0.49). PSM analysis showed similar findings. MT was not associated with an increased risk of sICH (4.0% vs. 2.1% in all patients; 4.2% vs. 2.4% in the PSM cohort).
MT in patients with pre-stroke mRS ≥3 might improve the 3-month outcomes and short-term neurological impairment, suggesting that pre-stroke disability alone should not be a reason to withhold MT, but that individual case-by-case decisions may be more appropriate.
Keywords
Disability, Handicapped, Outcome study, Pre-stroke, Stroke, Thrombectomy
Pubmed
Web of science
Open Access
Yes
Create date
17/10/2022 14:20
Last modification date
25/01/2024 8:43
Usage data